MODIFIED NUCLEOSIDES FOR THE TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION
申请人:GILEAD SCIENCES, INC.
公开号:US20140057863A1
公开(公告)日:2014-02-27
The disclosed invention is a composition for and a method of treating a Flaviviridae (including BVDV and HCV), Orthomyxoviridae (including Influenza A and B) or Paramyxoviridae (including RSV) infection, or conditions related to abnormal cellular proliferation, in a host, including animals, and especially humans, using a nucleoside of general formula (I)-(XXIII) or its pharmaceutically acceptable salt or prodrug.
This invention also provides an effective process to quantify the viral load, and in particular BVDV, HCV or West Nile Virus load, in a host, using real-time polymerase chain reaction (“RT-PCR”). Additionally, the invention discloses probe molecules that can fluoresce proportionally to the amount of virus present in a sample.
本公开发明涉及一种用于治疗Flaviviridae(包括BVDV和HCV)、Orthomyxoviridae(包括甲型和乙型流感病毒)或Paramyxoviridae(包括RSV)感染或与异常细胞增殖相关的条件的组合物和方法,适用于宿主,包括动物,特别是人类,使用一种核苷酸的一般式(I)-(XXIII)或其药学上可接受的盐或前药。本发明还提供了一种有效的过程,用于定量病毒载量,特别是BVDV、HCV或West Nile病毒载量,在宿主中使用实时聚合酶链反应(“RT-PCR”)。此外,本发明还揭示了可以与样品中存在的病毒数量成比例发光的探针分子。